Alivus Life Sciences Limited (ALSL) was formerly known as Glenmark Life Sciences Private Limited. The company is engaged in the business of development, manufacture, and marketing of Active Pharmaceutical Ingredients (API). The company’s product portfolio comprises various therapeutic segments, which include Cardiovascular (CVS) disease, Central Nervous System (CNS) disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. Its products include adapalene, alogliptin benzoate, amiodarone HCl, esomeprazole sodium, eszopiclone, etoricoxib, omeprazole, and oxcarbazepine. The company’s products also include vildagliptin, aprepitant, bosentan, cilostazol, deferasirox, fluconazole, ivacaftor, pirfenidone, riluzole, sucralfate, ticagrelor, telmisartan and umifenovir. The company’s research and development facilities are located at Mahape, Ankleshwar, and Dahej in India, and manufacturing facilities are located at Ankleshwar, Dahej, Mohol, and Kurkumbh.